# Tess Harris

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tess-harris/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,827 |
| Field | Dialysis and Renal Disease Management |
| h-index | 31 |
| i10-index | 56 |
| Last Known Institution | Polycystic Kidney Disease Foundation |
| OpenAlex ID | https://openalex.org/A5017323139 |
| ORCID iD | 0000-0003-3659-7438 |
| Works | 113 |

## Researcher papers

- [ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment](https://scholariq.org/papers/ispd-peritonitis-guideline-recommendations-2022-update-on-prevention-and/)
- [Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/autosomal-dominant-polycystic-kidney-disease-adpkd-executive-summary-from-a/)
- [Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey](https://scholariq.org/papers/developing-a-set-of-core-outcomes-for-trials-in-hemodialysis-an-international/)
- [Patient-centred approaches for the management of unpleasant symptoms in kidney disease](https://scholariq.org/papers/patient-centred-approaches-for-the-management-of-unpleasant-symptoms-in-kidney/)
- [Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop](https://scholariq.org/papers/implementing-core-outcomes-in-kidney-disease-report-of-the-standardized-outcomes/)
- [Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop](https://scholariq.org/papers/establishing-core-outcome-domains-in-hemodialysis-report-of-the-standardized/)
- [International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people](https://scholariq.org/papers/international-consensus-statement-on-the-diagnosis-and-management-of-autosomal/)
- [An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International](https://scholariq.org/papers/an-update-on-the-use-of-tolvaptan-for-autosomal-dominant-polycystic-kidney/)
- [Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study](https://scholariq.org/papers/patient-and-caregiver-priorities-for-outcomes-in-ckd-a-multinational-nominal/)
- [KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary](https://scholariq.org/papers/kdigo-2025-clinical-practice-guideline-for-the-evaluation-management-and/)
- [Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)](https://scholariq.org/papers/clinical-practice-guideline-monitoring-children-and-young-people-with-or-at-risk/)
- [Patient Perspectives on ADPKD](https://scholariq.org/papers/patient-perspectives-on-adpkd/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Healthcare cost, quality, practices](https://scholariq.org/topics/healthcare-cost-quality-practices/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [Polycystic Kidney Disease Foundation](https://scholariq.org/institutions/polycystic-kidney-disease-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.